Header Logo

Connection

STEPHEN PFLUGFELDER to Suspensions

Back to Details
This is a "connection" page, showing publications STEPHEN PFLUGFELDER has written about Suspensions.
STEPHEN PFLUGFELDER
Connection Strength
0.059
Suspensions
  1. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004 Sep; 138(3):444-57.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.